Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.19 -0.7%
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of product revenue: 5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA says momentum style supported by earnings revisions
- UBS says bull market has further to run
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
